Entries tagged "Genentech Inc."

Arthur Levinson to follow Eric Schmidt's lead?

Calls are increasing for Genentech chairman Arthur Levinson to follow Google CEO Eric Schmidt's lead and choose between directorships on the boards of Apple and Google to avoid antitrust violations.

Genentech rebuffs Roche tender

Genentech Inc. late Monday, Feb. 23, criticized Roche Holding AG's cut-price, $42 billion tender offer, highlighting its array of best-selling products and those still in the pipeline. Genentech's special board committee, in charge of negotiating with Roche since the Basel, Switzerland, company made its original $44 billion offer last July, surprised no one with Monday's unanimous recommendation to its shareholders to reject Roche's new tender offer. This is a free preview of the content available in The Deal Pipeline. Subscribers enjoy access to the full story, as well as second-to-none research tools. To request a demo, or, if you are...

Genentech stays the course

As expected, Genentech Inc.'s special committee of directors urged shareholders Monday to reject Roche Holding AG's $42 billion tender offer.

Here comes pharma's 'me-too' mergers

The pharmaceutical industry is notorious for creating copycat drugs. Now Pfizer's $68 billion bid for Wyeth could prompt Merck, Sanofi-Aventis and other peers to launch 'me-too' mergers.

Genentech to Roche: You're quite hostile

Genentech urged shareholders Friday afternoon to 'take no action' regarding Roche's hostile bid.

Genentech: Tied to the tracks?

Roche said early Friday it was lowering its offer to $86.50 a share and taking it hostile.

Genentech clinical trial could push Roche offer higher

Genentech Inc. said Wednesday it might see final data from a key clinical trial in April, an earlier-than-expected milestone that could influence the firm's ongoing takeover dance with majority owner Roche Holding AG....

Does morning in America mean a new day for VCs?

America may be at the dawn of a new era. No, not the Obama era, but a new era of venture capitalism and entrepreneurship. It may not come immediately, but it will come eventually, much like the earlier great eras of innovation, which sprang forth from the wreckage of an economic crisis....

Genentech's Levinson dishes, but not on Roche

As expected, Genentech Inc. CEO Art Levinson and other executives, appearing at the annual J.P. Morgan Chase & Co. healthcare conference in San Francisco, were tight-lipped Tuesday about the pending Roche Holding AG $44 billion acquisition offer. In his presentation Levinson steered clear of the topic completely, and in a packed Q&A session afterwards, he and his assembled team declined to comment on the latest reports of Roche possibly preparing a new bid. ...

Top tags

• M&A (1069)
• bankruptcy (544)
• private equity (520)
• politics (396)
• credit crisis (361)
• banks (354)
• Bank of America (349)
• banking (333)
• Citigroup (318)
• layoffs (313)